Cathie's Ark Logo
undefined Logo

ARKK Holdings of CRISPR Therapeutics (CRSP) - Updated Daily

TherapeuticsGene TherapyCAR-T Cell TherapyCRSPR Gene Editing
Date
Direction
Shares
Fund Weight
Fund
August 20, 2024
BUY116.319k0.0988%ARKK
August 7, 2024
BUY37.189k0.0345%ARKK
July 31, 2024
BUY14.582k0.0141%ARKK
May 30, 2024
BUY11.875k0.0103%ARKK
May 21, 2024
BUY60.174k0.0484%ARKK

Key Statistics

⚖️Weighting🧢Market Cap
5.42%$3.82b
🏋🏿‍♂️Weight Rank In ARKK🌏Country
2🇨🇭Switzerland
🏋️‍♀️Weight Rank Across All Funds💳ARK Estimated Cost Average
208$62.32
🎫ARK Ownership Percent
6.91%

Other ETFs That Hold CRSP

Ticker
NameWeight
ARKGARK Genomic Revolution ETF3.7%
GNOMGlobal X Genomics & Biotechnology ETF3.52%
ARKKARK Innovation ETF3.37%
XBISPDR® S&P Biotech ETF1.01%
IBBiShares Biotechnology ETF0.35%
LABUS&P Biotech Bull 3X Shares ETF0.242%

Research Notes and Commentary for CRSP

No Research Notes Found for CRSP